Cargando…
Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario
Autores principales: | Thakur, Sayanta, Chakraborty, Dwaipayan Sarathi, Lahiry, Sandeep, Choudhury, Shouvik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961090/ https://www.ncbi.nlm.nih.gov/pubmed/31898629 http://dx.doi.org/10.4103/lungindia.lungindia_291_19 |
Ejemplares similares
-
Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
por: Sarathi Chakraborty, Dwaipayan, et al.
Publicado: (2023) -
Effect of 1,25 dihydroxy vitamin D3 supplementation on pain relief in early rheumatoid arthritis
por: Mukherjee, Dibyendu, et al.
Publicado: (2019) -
Lefamulin, a recently approved novel antibacterial agent to fight against community-acquired bacterial pneumonia
por: Choudhury, Shouvik, et al.
Publicado: (2021) -
Advances in Vasodilatory Shock: A Concise Review
por: Lahiry, Sandeep, et al.
Publicado: (2019) -
Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times
por: Choudhury, Shouvik, et al.
Publicado: (2020)